Goldenwell Biotech (GWLL) Retained Earnings (2019 - 2025)
Goldenwell Biotech (GWLL) has disclosed Retained Earnings for 7 consecutive years, with -$1.4 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Retained Earnings fell 5.68% year-over-year to -$1.4 million, compared with a TTM value of -$1.4 million through Sep 2025, down 5.68%, and an annual FY2024 reading of -$1.4 million, down 10.71% over the prior year.
- Retained Earnings was -$1.4 million for Q3 2025 at Goldenwell Biotech, down from -$1.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$54810.0 in Q1 2021 and bottomed at -$1.4 million in Q3 2025.
- Average Retained Earnings over 5 years is -$853217.5, with a median of -$1.2 million recorded in 2023.
- The sharpest move saw Retained Earnings crashed 1598.76% in 2021, then dropped 5.68% in 2025.
- Year by year, Retained Earnings stood at -$125690.0 in 2021, then plummeted by 783.75% to -$1.1 million in 2022, then dropped by 10.57% to -$1.2 million in 2023, then dropped by 10.71% to -$1.4 million in 2024, then dropped by 3.5% to -$1.4 million in 2025.
- Business Quant data shows Retained Earnings for GWLL at -$1.4 million in Q3 2025, -$1.4 million in Q2 2025, and -$1.4 million in Q1 2025.